These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14527238)

  • 61. Reducing claims for prescription drugs with a high potential for abuse.
    Hoffman L; Enders JL; Pippins J; Segal R
    Am J Health Syst Pharm; 2003 Feb; 60(4):371-4. PubMed ID: 12625220
    [No Abstract]   [Full Text] [Related]  

  • 62. Drug utilization in primary healthcare centres in the Gaza Strip.
    Ayoub SW; Musalam AH; Abu Mahadi AA
    East Mediterr Health J; 2017 Dec; 23(10):649-656. PubMed ID: 29270964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmaceutical prescriptions in Italy.
    Garattini S
    Int J Technol Assess Health Care; 1995; 11(3):417-27. PubMed ID: 7591544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessing prescribing practice in church-owned primary healthcare (PHC) institutions in Tanzania: a pilot study.
    Nsimba SE; Massele AY; Makonomalonja J
    Trop Doct; 2004 Oct; 34(4):236-8. PubMed ID: 15510956
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent changes in the profile of prescription NSAID use in Australia.
    McManus P; Henry DA; Birkett DJ
    Med J Aust; 2000 Feb; 172(4):188. PubMed ID: 10772594
    [No Abstract]   [Full Text] [Related]  

  • 66. Impact of physicians' participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study in Germany.
    Koch C; Schleeff J; Techen F; Wollschläger D; Schott G; Kölbel R; Lieb K
    PLoS Med; 2020 Jun; 17(6):e1003151. PubMed ID: 32589633
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PACT level 3--a tool for audit.
    Heywood P
    Practitioner; 1991 May; 235(1502):450-1. PubMed ID: 1924128
    [No Abstract]   [Full Text] [Related]  

  • 68. Examining product risk in context. Market withdrawal of zomepirac as a case study.
    Ross-Degnan D; Soumerai SB; Fortess EE; Gurwitz JH
    JAMA; 1993 Oct; 270(16):1937-42. PubMed ID: 8411550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 70. Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria.
    Oshikoya KA; Oreagba I; Adeyemi O
    Pan Afr Med J; 2011; 9():13. PubMed ID: 22145057
    [TBL] [Abstract][Full Text] [Related]  

  • 71. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    Mark TL
    CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The latest trends in the pharmaceutical market.
    Teitelbaum F
    Case Manager; 2000; 11(5):70-4. PubMed ID: 11935588
    [No Abstract]   [Full Text] [Related]  

  • 73. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
    Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
    Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of medication in children with psychiatric disorders.
    Barton R
    Community Pract; 2007 Nov; 80(11):42, 44. PubMed ID: 18064853
    [TBL] [Abstract][Full Text] [Related]  

  • 75. After years of steady growth, winds of restraint blowing on prescription-drug industry.
    Robinson A
    CMAJ; 1995 Jul; 153(1):85-8. PubMed ID: 7796380
    [TBL] [Abstract][Full Text] [Related]  

  • 76. What do we know about direct-to-consumer advertising of prescription drugs?
    Calfee JE
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-116-9. PubMed ID: 14527242
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inappropriate medication prescribing for the elderly by office-based physicians.
    Aparasu RR; Fliginger SE
    Ann Pharmacother; 1997; 31(7-8):823-9. PubMed ID: 9220038
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting.
    Fortess EE; Soumerai SB; McLaughlin TJ; Ross-Degnan D
    J Am Geriatr Soc; 2001 Jun; 49(6):793-7. PubMed ID: 11454120
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Do medical education and practice characteristics predict inappropriate prescribing of sedative-hypnotics for the elderly?
    Monette J; Tamblyn RM; McLeod PJ; Gayton DC; Laprise R
    Acad Med; 1994 Oct; 69(10 Suppl):S10-2. PubMed ID: 7916812
    [No Abstract]   [Full Text] [Related]  

  • 80. Interpreting and analysing practice prescribing data.
    Nicholls J
    Community Nurse; 2000 Jul; 6(6):39-42. PubMed ID: 12778649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.